secwatch.observer — SEC 8-K summary
======================================

Issuer:     RESMED INC (RMD)
CIK:        0000943819
Form:       8-K
Filed at:   2022-07-01T23:59:59+00:00
Accession:  0001193125-22-187014
Event type: leadership
Sentiment:  neutral
Materiality: 0.45
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ResMed promotes Lucile Blaise to President of Sleep & Respiratory Care effective July 1
--------------------------------------------------------------------------------

- Lucile Blaise, previously VP of Sleep & Respiratory Care for Western Europe, promoted to President of global Sleep & Respiratory Care, effective July 1, 2022.
- Blaise has over 25 years in medtech, including 16 years at ResMed; elected President of Snitem in June 2022 and serves on MedTech Europe board.
- Compensation: annual base salary $470,000, target STI 80%, equity target $1,400,000, plus relocation benefits for move to U.S.
- Robert Douglas will cease as interim President of the business but remains President and COO of ResMed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/943819/000119312522187014/0001193125-22-187014-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/943819/000119312522187014/d360618d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-187014

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer